baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Genmab A/S/ DK0010272202 /

1/30/2023 4:54:43 PM	Chg. +9.00	Volume	Bid4:55:00 PM	Ask4:55:00 PM	Market Capitalization	Dividend Y.	P/E Ratio
2,664.00DKK	+0.34%	41,254 Turnover: 36.9 mill.	-Bid Size: -	-Ask Size: -	174.94 bill.DKK	-	57.87

GlobeNewswire 3/15/2022 Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of the...

GlobeNewswire 3/8/2022 BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and ...

GlobeNewswire 2/24/2022 Notice to Convene the Annual General Meeting of Genmab A/S

pressetext 2/21/2022 PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell recepto...

GlobeNewswire 2/21/2022 BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Again...

GlobeNewswire 2/16/2022 Genmab Publishes 2021 Annual Report

GlobeNewswire 2/16/2022 BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production...

GlobeNewswire 2/15/2022 BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference to Provide...

GlobeNewswire 2/1/2022 Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Va...

GlobeNewswire 1/25/2022 Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Yea...

GlobeNewswire 1/25/2022 Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021

GlobeNewswire 1/11/2022 BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential Hi...

GlobeNewswire 1/10/2022 BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision I...

GlobeNewswire 1/5/2022 Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vac...

GlobeNewswire 12/27/2021 BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 12/9/2021 Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Ind...

GlobeNewswire 12/8/2021 BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant

GlobeNewswire 12/8/2021 Pfizer and BioNTech Provide Update on Omicron Variant

GlobeNewswire 11/25/2021 Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of ...

GlobeNewswire 11/22/2021 Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Effica...

GlobeNewswire 11/19/2021 Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booste...

GlobeNewswire 11/19/2021 Bolt Biotherapeutics Announces Changes to its Board of Directors

GlobeNewswire 11/19/2021 BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma

GlobeNewswire 11/11/2021 Zipline, Pfizer and BioNTech Collaboration Paves the Way for Automated, On-Demand Delivery of First ...

GlobeNewswire 11/10/2021 Genmab Announces Financial Results for the First Nine Months of 2021

Genmab A/S/ DK0010272202 /

If you wish to receive reply to your feedback, please provide your email address.